Jump to content

palbociclib (Q15269707)

From Wikidata
drug for the treatment of ER-positive and HER2-negative breast cancer developed by Pfizer
  • PD-0332991
  • PD0332991
  • PD 332991
  • PD 0332991
  • 6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one
  • 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one
edit
Language Label Description Also known as
default for all languages
No label defined
    English
    palbociclib
    drug for the treatment of ER-positive and HER2-negative breast cancer developed by Pfizer
    • PD-0332991
    • PD0332991
    • PD 332991
    • PD 0332991
    • 6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one
    • 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one

    Statements

    0 references
    Palbociclib.svg
    512 × 267; 7 KB
    0 references
    C₂₄H₂₉N₇O₂
    1 reference
    CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C
    1 reference
    447.238 dalton
    1 reference
    Palbociclib
    0 references

    Identifiers

    10219048
    1 reference
    0 references
    1 reference
    27 December 2018
    6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one (English)
    CAS no.: 571190-30-2 (English)
    1 reference
    27 December 2018
    6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one (English)
    CAS no.: 571190-30-2 (English)
    0 references
    1 reference
    0 references
    0 references
     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit